ATE460167T1 - Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe - Google Patents
Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffeInfo
- Publication number
- ATE460167T1 ATE460167T1 AT05821493T AT05821493T ATE460167T1 AT E460167 T1 ATE460167 T1 AT E460167T1 AT 05821493 T AT05821493 T AT 05821493T AT 05821493 T AT05821493 T AT 05821493T AT E460167 T1 ATE460167 T1 AT E460167T1
- Authority
- AT
- Austria
- Prior art keywords
- rapid
- active ingredients
- poorly soluble
- soluble active
- medicinal products
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63811104P | 2004-12-23 | 2004-12-23 | |
EP04106933 | 2004-12-23 | ||
PCT/EP2005/056970 WO2006067150A1 (en) | 2004-12-23 | 2005-12-20 | Oral immediate release formulation of a poorly watersoluble active substance |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE460167T1 true ATE460167T1 (de) | 2010-03-15 |
Family
ID=34930144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05821493T ATE460167T1 (de) | 2004-12-23 | 2005-12-20 | Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1848439B1 (de) |
JP (1) | JP2008525368A (de) |
CN (1) | CN101087612A (de) |
AR (1) | AR051727A1 (de) |
AT (1) | ATE460167T1 (de) |
AU (1) | AU2005318199B2 (de) |
BR (1) | BRPI0519248A2 (de) |
CA (1) | CA2590848A1 (de) |
ES (1) | ES2342548T3 (de) |
MX (1) | MX2007007609A (de) |
PL (1) | PL1848439T3 (de) |
RU (1) | RU2382649C2 (de) |
SA (1) | SA05260422B1 (de) |
TW (1) | TW200633713A (de) |
UA (1) | UA90700C2 (de) |
WO (1) | WO2006067150A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
EA014898B1 (ru) * | 2006-06-16 | 2011-02-28 | Солвей Фармасьютикалс Б.В. | Пероральная фармацевтическая композиция из активного вещества, плохо растворимого в воде |
JP2009541267A (ja) * | 2006-06-22 | 2009-11-26 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | 低い水溶性活性物質の経口製薬学的組成物 |
WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19638020A1 (de) * | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
AR038681A1 (es) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua |
WO2004062692A1 (en) * | 2003-01-13 | 2004-07-29 | Solvay Pharmaceuticals B.V. | Formulation of poorly water-soluble active substances |
-
2005
- 2005-12-19 TW TW094145083A patent/TW200633713A/zh unknown
- 2005-12-20 SA SA5260422A patent/SA05260422B1/ar unknown
- 2005-12-20 BR BRPI0519248-0A patent/BRPI0519248A2/pt not_active IP Right Cessation
- 2005-12-20 CN CNA200580044355XA patent/CN101087612A/zh active Pending
- 2005-12-20 AR ARP050105358A patent/AR051727A1/es not_active Application Discontinuation
- 2005-12-20 PL PL05821493T patent/PL1848439T3/pl unknown
- 2005-12-20 MX MX2007007609A patent/MX2007007609A/es active IP Right Grant
- 2005-12-20 AU AU2005318199A patent/AU2005318199B2/en not_active Ceased
- 2005-12-20 JP JP2007547492A patent/JP2008525368A/ja not_active Withdrawn
- 2005-12-20 WO PCT/EP2005/056970 patent/WO2006067150A1/en active Application Filing
- 2005-12-20 EP EP05821493A patent/EP1848439B1/de active Active
- 2005-12-20 CA CA002590848A patent/CA2590848A1/en not_active Abandoned
- 2005-12-20 UA UAA200708357A patent/UA90700C2/ru unknown
- 2005-12-20 RU RU2007127847/15A patent/RU2382649C2/ru not_active IP Right Cessation
- 2005-12-20 ES ES05821493T patent/ES2342548T3/es active Active
- 2005-12-20 AT AT05821493T patent/ATE460167T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101087612A (zh) | 2007-12-12 |
BRPI0519248A2 (pt) | 2009-01-06 |
JP2008525368A (ja) | 2008-07-17 |
AU2005318199A1 (en) | 2006-06-29 |
AU2005318199B2 (en) | 2011-04-28 |
MX2007007609A (es) | 2007-08-03 |
TW200633713A (en) | 2006-10-01 |
RU2007127847A (ru) | 2009-01-27 |
EP1848439B1 (de) | 2010-03-10 |
WO2006067150A1 (en) | 2006-06-29 |
PL1848439T3 (pl) | 2010-11-30 |
CA2590848A1 (en) | 2006-06-29 |
UA90700C2 (ru) | 2010-05-25 |
SA05260422B1 (ar) | 2009-09-08 |
RU2382649C2 (ru) | 2010-02-27 |
ES2342548T3 (es) | 2010-07-08 |
EP1848439A1 (de) | 2007-10-31 |
AR051727A1 (es) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181819T1 (hr) | Formulacija krutog farmaceutskog oblika doziranja koja sadrži lopinavir | |
MA28489B1 (fr) | Preparations pharmaceutiques | |
ZA200605631B (en) | Directly compressible pharmaceutical composition for the oral administration of CCI-779 | |
DE60316323D1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
EP1919288A4 (de) | Famotidin- und ibuprofenhaltige arzneimittel und ihre verabreichung | |
IL191804A0 (en) | Solid dispersion containing an active ingredient and tablets for oral administration containing the same | |
DE602005021475D1 (de) | Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423) | |
MA29076B1 (fr) | Préparations pharmaceutiques comprenant un dérivé de camptothécine | |
ATE439832T1 (de) | Feste pharmazeutische arzneimittelformulierung enthaltend diacerein und meloxicam | |
NO20043832L (no) | Oral fast losningsformulering av en darlig vannloselig aktiv substans | |
NO20055601D0 (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
ATE549016T1 (de) | Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe | |
FR2888748B1 (fr) | Composes neuroprotecteurs et compositions pharmaceutiques les comprenant | |
ATE460167T1 (de) | Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe | |
FR2852845B1 (fr) | Compositions pharmaceutiques a activite antibiotique | |
DE60037897D1 (de) | Orales arzneimittel mit verzögerter wirkstoffabgabe | |
ECSP067030A (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
DK1750765T3 (da) | Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel | |
HK1122731A1 (en) | Prolonged release formulation of active pharmaceutical ingredients | |
MA28485B1 (fr) | Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises | |
DE602005019919D1 (de) | Oral anzuwendende schnellfreisetzende arzneimittel schwer löslicher wirkstoffe | |
DE112004002737D2 (de) | Lösungsmittel für biogene pharmazeutische Wirkstoffe | |
DE602006012346D1 (de) | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel | |
GB0317345D0 (en) | Formulation for the administration of medicinal substances | |
IL195653A0 (en) | Oral pharmaceutical composition of a poorly water-soluble active substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |